(Q37907067)

25 August 2017

1 reference

title

Management of hyperlipidemia of kidney disease (English)

1 reference

25 August 2017

1 reference

Grundy SM

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 March 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

37

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

847-853

1 reference

Cholesterol and coronary heart disease. A new era.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

A new challenge for America: the National Cholesterol Education Program

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Hyperlipoproteinemia in nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Plasma Triglyceride Metabolism in the Adult Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Serum lipid and lipoprotein alterations in nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Lipoprotein lipid and protein synthesis in experimental nephrosis and plasmapheresis. I: Studies in rat in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Hepatic Secretion of Lipoproteins in the Rat and the Effect of Experimental Nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Lipoprotein lipase in clinical and experimental nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Separation of a lipoprotein lipase cofactor from the alpha 1-acid glycoprotein fraction from the urine of nephrotic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Mechanisms of hyperlipemia in experimental nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

The Nephrotic Syndrome and Ischaemic Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Ischaemic heart-disease as a complication of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Fibric acids: effects on lipids and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Letter: Clofibrate and gallstones

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Probucol inhibits oxidative modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Effect of probucol on hyperlipidemia in patients with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Hypertriglyceridemia. A metabolic consequence of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Serum apolipoprotein profile of patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Increased lipoprotein-remnant formation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Effect of acute uremia on triglyceride kinetics in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Plasma lipid alterations in patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Hypertriglyceridemia: causes and relation to coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Adipose Tissue Lipoprotein Lipase in Chronic Hemodialysis: Role in Plasma Triglyceride Metabolism*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Selective Deficiency of Hepatic Triglyceride Lipase in Uremic Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Lipids and Lipoproteins in Chronic Uraemia. A Study of the Influence of Regular Haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Accelerated atherosclerosis in prolonged maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Atherosclerosis in uremia: a longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Influence of plasma triglycerides on lipoprotein patterns in normal subjects and in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Chylomicron clearance in normal and hyperlipidemic man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Lipoprotein predictors of the severity of coronary artery disease in men and women

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Reduction of plasma triglycerides by diet in subjects with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Response of plasma triglycerides to dietary change in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Untoward effects of clofibrate in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Hyperlipidaemia after successful renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Lipid Disorders in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Hyperlipidemia After Renal Transplantation: Natural History and Pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Lipid abnormalities in uremia, dialysis, and transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Persistent hyperlipidemia in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Normal serum-lipids in renal-transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.57

7 January 2021

Identifiers

DOI

10.1038/KI.1990.57

1 reference

25 August 2017

1 reference